Cite

HARVARD Citation

    Jewell, R. et al. (2017). Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy. Leukemia & lymphoma. 58 (2), pp. 348-356. [Online]. 
  
Back to record